CEO: Michael D. Clayman

Sector: Healthcare

Exchange: NASDAQ Global Market

Country: USA

Description: Flexion Therapeutics Inc is a development stage specialty pharmaceutical company. The Company is engaged in the development and commercialization of novel, long-acting, injectable pain therapies including anti-inflammatory and analgesic therapies.


Key numbers

Market Capitalization:671880000
Shares Outstanding: 38175000
Float: 31933655
Next Earning Date:2020-03-06
TTm EPS: -4.1276
TTm Dividend Rate:
200 days moving average:13.94
50 days moving average: 18.68
One day percent Change: 0.11



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,